Top Markets
Coin of the day
Moleculin Biotech, Inc. Moleculin Biotech, Inc.

Moleculin Biotech, Inc.

MBRX
Rankning i aktier #35911
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to... Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in Phase I studies, targeting both adult and pediatric brain tumors, pancreatic cancer, and other types of aggressive malignancies. Further, the firm is developing WP1220, an analog of WP1066, intended for topical application in treating cutaneous T-cell lymphoma. Another compound, WP1122, is under development for glioblastoma multiforme and COVID-19. Moleculin Biotech has established collaboration agreements and partnerships with organizations such as MD Anderson, Animal Life Sciences, LLC, and WPD Pharmaceuticals Sp z.o.o. The company was founded in 2015 and maintains its principal offices in Houston, Texas.
Aktiekurs
$0.6155
Senast synkroniserad: 2026-08-14
Marknadsvärde
$3.28M
Förändring (1 dag)
7.74%
Förändring (1 år)
-96.39%
Land
US
Handel Moleculin Biotech, Inc. (MBRX)

Kategori

Aktiekurshistorik för Moleculin Biotech, Inc. (MBRX)
Högsta slutkurs: $0.48 den 2026-08-01

Lägsta slutkurs: $16.17K den 2016-06-01
Aktiekurshistorik för Moleculin Biotech, Inc. från 2016 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 8.33%
2025 -90.56%
2024 -77.07%
2023 -51.53%
2022 -36.45%
2021 -59.01%
2020 -17.81%
2019 -15.25%
2018 -35.47%
2017 -12.10%
2016 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE